Premium Company Profile: Endo Pharmaceuticals

Publication Date	November 2007
Publisher	Datamonitor
Product Type	Report
Pages	58
ISBN Number	not applicable
Product Code	DAT08654

Price

£265.00
approximately: $495 | €336

PDF

PRINT £315 ($589 | €400)

Order above formats by FAX

Summary

Endo Pharmaceuticals' main focus is to develop and market prescription drugs for pain management. The company's marketed product, Lidoderm, indicated for the relief of pain associated with post-herpetic neuralgia, has been the major contributor to its revenues. Further, the company's acquisition of RxKinetix in 2006 provided an expansion of the company into therapeutic areas.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals. The company has a portfolio of branded products that includes: Lidoderm, Percocet, Frova, Percodan, Opana, Opana ER and Synera.

The company's lead product candidate EN 3285 Oral Rinse for treating Oral mucositis is currently in Phase 2 clinical trials. In addition, Endo Pharmaceuticals has two licensed products in Phase 3 namely: topical ketoprofen patch and rapinyl used for treating pain associated with soft tissue injuries and cancer, respectively.

Endo Pharmaceuticals derives its revenues from product sales of its proprietary and in-licensed products. The company's total revenues increased at a CAGR of 10.9% during 2002-2006, from $399 million to $909.7 million. This represents an absolute total growth of +$510 million for total revenues.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Table Of Contents
- Overview
- Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Strategy
- Swot Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery And Product Development
- Manufacturing
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table Of Figures
- Figure 1: Endo Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Endo Pharmaceuticals - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Endo Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
Table Of Tables
- Table 1: Endo Pharmaceuticals - Key Facts
- Table 2: Endo Pharmaceuticals - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 3: Endo Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 4: Endo Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Endo Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 6: Endo Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Endo Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Endo Pharmaceuticals - Marketed Products
- Table 9: Endo Pharmaceuticals - In-House Pipeline Products
- Table 10: Endo Pharmaceuticals - Licensed Products
- Table 11: Endo Pharmaceuticals - Historical Product Sales, 2002-2006 ($ Mn)
- Table 12: Endo Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 13: Endo Pharmaceuticals - Key Competitors
- Table 14: Endo Pharmaceuticals - Key Suppliers
- Table 15: Endo Pharmaceuticals - Key Shareholders
- Table 16: Endo Pharmaceuticals - Swot Analysis
- Table 17: Endo Pharmaceuticals - Value Chain Analysis
- Table 18: Endo Pharmaceuticals - Scorecard
- Table 19: Endo Pharmaceuticals - Key Employees
- Table 20: Endo Pharmaceuticals - Financial And Operational Overview